PanCareSurPass Project HL7 FHIR Implementation Guide
1.0.0 - release 150

PanCareSurPass Project HL7 FHIR Implementation Guide, published by PanCareSurPass Project. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/pcsp/ and changes regularly. See the Directory of published versions

CodeSystem: PCSP Conditions at risk

Official URL: http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp Version: 1.0.0
Active as of 2025-10-16 Computable Name: CsRiskConditionPcsp

Condition at risk proposed by the PCSP algorithm

This Code system is referenced in the content logical definition of the following value sets:

This case-sensitive code system http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp defines the following codes:

CodeDisplayDefinition
1 Subsequent thyroid cancer Subsequent thyroid cancer
2 Subsequent breast cancer Subsequent breast cancer
3 Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
4 Impaired fertility Impaired spermatogenesis Impaired fertility Impaired spermatogenesis
5 Testosterone deficiency Testosterone deficiency
6 Physical sexual dysfunction Physical sexual dysfunction
7 Premature ovarian insufficiency Premature ovarian insufficiency
8 Ear problems Ear problems
9 Impaired glucose metabolism and diabetes melitus Impaired glucose metabolism and diabetes melitus
10 Dyslipidemia Dyslipidemia
11 Overweight and obesity Overweight and obesity
12 Hypertension Hypertension
13 Reduced bone mineral density Reduced bone mineral density
14 Osteonecrosis Osteonecrosis
15 Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
16 Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
17 Central precocious puberty (CPP) For girls with age below 8 years Central precocious puberty (CPP) For girls with age below 8 years
18 Central precocious puberty (CPP) For boys with age below 9 yearss Central precocious puberty (CPP) For boys with age below 9 yearss
19 Thyroid function problems Thyroid function problems
20 Cerebrovascular problem Cerebrovascular problem
21 Neurocognitive problems Neurocognitive problems
22 Peripheral neuropathy Peripheral neuropathy
23 Cataract Cataract
24 Eye problems Eye problems
25 Craniofacial growth problems Craniofacial growth problems
26 Spine scoliosis and kyphosis Spine scoliosis and kyphosis
27 Lower urinary tract problems Lower urinary tract problems
28 Obstetric problems Obstetric problems
29 Dental and oral problems Dental and oral problems
30 Gastro-intestinal problems Gastro-intestinal problems
31 Arrhythmia Arrhythmia
32 Pulmonary problems Pulmonary problems
33 Renal problems (Glomerular dysfunction - Tubular dysfunction) Renal problems (Glomerular dysfunction - Tubular dysfunction)
34 Liver problems Liver problems
35 Iron overload Iron overload
36 Spleen problems Spleen problems
37 Tumor predisposition Tumor predisposition
38 Subsequent melanoma and non-melanoma skin cancer Subsequent melanoma and non-melanoma skin cancer
39 Subsequent colorectal cancer Subsequent colorectal cancer
40 Subsequent Oral Cancer Subsequent Oral Cancer
41 Subsequent acute myeloid leukaemia or myelodysplasia Subsequent acute myeloid leukaemia or myelodysplasia
42 Subsequent bladder cancer Subsequent bladder cancer
43 Subsequent Bone Cancer Subsequent Bone Cancer
44 Subsequent lung cancer Subsequent lung cancer
45 Subsequent CNS neoplasms Subsequent CNS neoplasms
46 Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
47 Renal problems (Tubular dysfunction) Renal problems (Tubular dysfunction)